- UPSpace Home
- →
- Health Sciences
- →
- Pharmacology
- →
- Browsing Pharmacology by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Pharmacology by Subject "Safety"
Now showing items 1-6 of 6
-
Evaluating the efficacy, safety and possible mechanism of action of potassium humate with selenium (University of Pretoria, 2013)Aim. The aim of the study was to evaluate the efficacy, safety and possible mechanism of action of potassium humate loaded with selenium Objectives. The objectives of the study were to evaluate the possible in vitro ...
-
(Medpharm Publications, 2016)Since their introduction in 1987, statins have become the largest-selling prescription drugs worldwide, and have kept both the scientific and lay press captivated. This year alone has seen reports that statins may prevent ...
-
(Elsevier, 2019-09)PURPOSE : Temelimab/GNbAC1 is a humanized immunoglobulin G4 monoclonal antibody antagonist of the human endogenous retrovirus W envelope protein, which is associated with multiple sclerosis (MS) pathophysiology and possibly ...
-
Ok, so who wants to colonise my gut? - Overview of probiotics in certain gastro-intestinal disorders (Medpharm Publications, NISC (Pty) Ltd and Cogent, Taylor and Francis Group, 2017)Probiotics are being used and perhaps more often than not as a treatment for a variety of gastrointestinal (GI) disorders. With increasing frequency, it is also being advocated as a treatment for several medical conditions, ...
-
(Dove Press, 2012-02-16)BACKGROUND: The purpose of this research was to determine the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid (CHD-FA). METHODS: In this double-blind study, 30 male volunteers ...
-
(Elsevier, 2015-08)GNbAC1 is a humanized monoclonal antibody targeting MSRV-Env, an endogenous retroviral protein, which is expressed inmultiple sclerosis (MS) lesions, is pro-inflammatory and inhibits oligodendrocyte precursor cell ...
Now showing items 1-6 of 6